Works about HYALURONIDASES


Results: 489
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Salicornia ramosissima : A New Green Cosmetic Ingredient with Promising Skin Effects.

    Published in:
    Antioxidants, 2022, v. 11, n. 12, p. 2449, doi. 10.3390/antiox11122449
    By:
    • Correia, Ana;
    • Silva, Ana Margarida;
    • Moreira, Manuela M.;
    • Salazar, Miguel;
    • Švarc-Gajić, Jaroslava;
    • Brezo-Borjan, Tanja;
    • Cádiz-Gurrea, Maria de la Luz;
    • Carretero, Antonio Segura;
    • Loschi, Francesca;
    • Dall'Acqua, Stefano;
    • Delerue-Matos, Cristina;
    • Rodrigues, Francisca
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Analytical methods for honeybee venom characterization.

    Published in:
    Journal of Advanced Pharmaceutical Technology & Research, 2022, v. 13, n. 3, p. 154, doi. 10.4103/japtr.japtr_166_21
    By:
    • El Mehdi, Iouraouine;
    • Falcão, Soraia;
    • Boujraf, Saïd;
    • Mustapha, Harandou;
    • Campos, Maria;
    • Vilas-Boas, Miguel
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Safety, Tolerability, and Pharmacokinetics of High‐Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers.

    Published in:
    Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1337, doi. 10.1002/cpt.2385
    By:
    • Dolton, Michael J.;
    • Chesterman, Aaron;
    • Moein, Anita;
    • Sink, Kaycee M.;
    • Waitz, Ariel;
    • Blondeau, Kathleen;
    • Kerchner, Geoffrey A.;
    • Hu, Nan;
    • Brooks, Logan;
    • Wetzel‐Smith, Monica K.;
    • Roden, Amanda;
    • Deshmukh, Ajay;
    • Peng, Kun;
    • Carrasco‐Triguero, Montserrat;
    • Smith, Jill;
    • Ostrowitzki, Susanne;
    • Quartino, Angelica
    Publication type:
    Article
    38
    39
    40

    Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 499, doi. 10.1007/s00280-021-04296-0
    By:
    • Wang, Bei;
    • Deng, Rong;
    • Hennig, Stefanie;
    • Badovinac Crnjevic, Tanja;
    • Kaewphluk, Monika;
    • Kågedal, Matts;
    • Quartino, Angelica L.;
    • Girish, Sandhya;
    • Li, Chunze;
    • Kirschbrown, Whitney P.
    Publication type:
    Article
    41
    42
    43

    EXPERIMENTAL ISCHEMIA.

    Published in:
    Nephrology Dialysis Transplantation, 2014, v. 29, n. suppl_3, p. iii56, doi. 10.1093/ndt/gfu135
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50